StockData
ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Electra Therapeutics, Inc.

$8.61−0.14 (-1.60%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Electra Therapeutics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Electra Therapeutics filed with the SEC